Parallax Volatility Advisers, L.P. Reata Pharmaceuticals Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $2.52 Million - $7.62 Million	81,800 New	81,800 $7.44 Million
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $1.89 Million - $2.66 Million	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $2.04 Million - $3.69 Million	20,000 New	20,000 $2.47 Million
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $177,707 - $310,346	-1,900 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $113,670 - $158,904	900 Added 90.0%	1,900 $299,000
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $124,160 - $247,740	1,000 New	1,000 $142,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.